Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novozyme To Set Up Its First Pharmaceutical Company In Tianjin

This article was originally published in PharmAsia News

Executive Summary

Denmark-based Novozyme recently started constructing its biopharmaceutical base in Tianjin's Binhai new district, its first such project in China. This represents the company's second key project after its enzyme formulation plant in the city. With a first phase investment of $70 million, the new facility will mainly produce hyaluronic acid raw drug materials and is expected to start operation by the end of 2010. Novozyme attributes the latest move to Tianjin's solid market conditions and will continue to increase investment if everything goes on track smoothly. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071652

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel